Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial Nature Nawigacja wpisu Newly developed shelf-stable synthetic blood could change battlefield medicine – Military Times WVU Medicine helps Morgantown coach defeat chronic joint pain – WVU Medicine
